Abstract
It has been reported that the incidence of angiotensin-converting enzyme (ACE) inhibitor-related dry cough is significantly less with the ACE inhibitor imidapril than with the ACE inhibitor enalapril in hypertensive patients. Bradykinin (BK) in the trachea is believed to play some role in this adverse effect. The present study was undertaken to evaluate the effects of imidapril and enalapril on the activity of aminopeptidase P (APP), one of the BK-metabolizing enzymes, in the mouse trachea. Imidapril (0.5 mg/kg) or enalapril (0.5 mg/kg) was given orally to mice once daily for 7 days. Drug concentrations and APP activity in the trachea were determined at the end of the experiment. Active metabolites (imidaprilat and enalaprilat), but not parent drugs (imidapril and enalapril) were detected in the trachea after a repeated dose for 7 days. Tissue concentrations of imidaprilat and enalaprilat did not significantly differ. The APP activity in the trachea did not significantly change after the 7th dose of imidapril. However, the enzyme activity was significantly inhibited after the final dose of enalapril. Thus, the present study showed that enalapril, but not imidapril inhibited the airway APP activity during repeated dosing. This finding is compatible with previous reports that the incidence of dry cough is lower with imidapril than with enalapril, and with the hypothesis that the dry cough induced by ACE inhibitors may be related to accumulation of BK in the trachea.
Similar content being viewed by others
Article PDF
References
Jackson EK, Garrison JC : Renin and angiotensin, in Hardman JG, Limbird LE ( eds): Goodman & Gilman's the Pharmacological Basis of Therapeutics. 9th ed. New York, McGraw-Hill, 1996, pp 733–758.
Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ : Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 1996; 2: 814–817.
Saruta T, Omae T, Kuramochi M, et al: Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control. J Hypertens 1995; 13 ( Suppl 3): S23–S30.
Saruta T, Arakawa K, Iimura O, et al: Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate. Hypertens Res 1999; 22: 197–202.
Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA : Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995; 47: 25–49.
Sakamoto K, Sugimoto K, Fujimura A : Different potentiating effects of imidapril and enalapril on kaolin-induced writhing reaction in mice. Life Sci 2001; 68: 2415–2421.
Sakamoto K, Sugimoto K, Fujimura A : Different inhibition of enalaprilat and imidaprilat on bradykinin metabolizing enzymes. Life Sci 2000; 67: 2159–2165.
Kasahara Y, Ashihara Y : Colorimetry of angiotensin-converting enzyme activity in serum. Clin Chem 1981; 27: 1922–1925.
Holtzman EJ, Pillay G, Rosenthal T, Yaron A : Aminopeptidase P activity in rat organs and human serum. Anal Biochem 1987; 162: 476–484.
Mabuchi M, Kano Y, Fukuyama T, Kondo T : Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr 1999; 734: 145–153.
Squire IB, O'kane KPJ, Anderson N, Reid JL : Bradykinin B2 receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension 2000; 36: 132–136.
Zee RYL, Rao VS, Paster RZ, Sweet CS, Lindpaintner K : Three candidate genes and angiotensin-converting enzyme inhibitor-related cough. Hypertension 1998; 31: 925–928.
Mukae S, Aoki S, Itoh S, Iwata T, Ueda H, Katagiri T : Bradykinin B2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension 2000; 36: 127–131.
Sumino H, Ichikawa S, Ohyama Y, et al: Effect of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. Hypertens Res 2003; 26: 53–58.
Murata T, Matsumoto Y, Kashida T, et al: Difference among angiotensin-converting enzyme inhibitors in potentiating effects on bradykinin-induced airway microvascular leakage in guinea pig airways. Jpn J Pharmacol 1995; 69: 111–118.
Damas J, Liégeois J-F, Simmons WH : Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws. Naunyn-Schmiederbergs Arch Pharmacol 1996; 354: 670–676.
Kim K-S, Kumar S, Simmons WH, Brown NJ : Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans. J Pharmacol Exp Ther 2000; 292: 295–298.
Emanueli C, Grady EF, Madeddu P, et al: Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension 1998; 31: 1299–1304.
Morice AH, Brown MJ, Higenbottam T : Cough associated with angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 1989; 13 ( Suppl 3): S59–S62.
Regoli D, Barabe J : Pharmacology of bradykinin and related peptides. Pharmacol Rev 1980; 32: 1–46.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakamoto, Ki., Sugimoto, Ki., Sudoh, T. et al. Different Effects of Imidapril and Enalapril on Aminopeptidase P Activity in the Mouse Trachea. Hypertens Res 28, 243–247 (2005). https://doi.org/10.1291/hypres.28.243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.243